Key Applications Driving the Sunitinib Malate Market Forward
The Sunitinib Malate Market is developing alongside the growing demand for targeted cancer therapies and advances in precision oncology. Sunitinib malate is an oral, multi-targeted tyrosine kinase inhibitor used in the treatment of several cancers, including kidney cancer, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (PNET). According to Polaris Market...
0 Comentários 0 Compartilhamentos 20 Visualizações 0 Anterior